{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:06:33Z","timestamp":1786993593573,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.juro.2017.11.096","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T05:06:43Z","timestamp":1512191203000},"page":"1158-1165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study"],"prefix":"10.1097","volume":"199","author":[{"given":"Siamak","family":"Daneshmand","sequence":"first","affiliation":[{"name":"University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[{"name":"University of Oklahoma, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Pohar","sequence":"additional","affiliation":[{"name":"Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Trabulsi","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woods","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Downs","sequence":"additional","affiliation":[{"name":"University of Wisconsin, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Huang","sequence":"additional","affiliation":[{"name":"New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Jones","sequence":"additional","affiliation":[{"name":"Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinity","family":"Bivalacqua","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"DeCastro","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Steinberg","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kamat","sequence":"additional","affiliation":[{"name":"University of Texas M. D. Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Resnick","sequence":"additional","affiliation":[{"name":"Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrinath","family":"Konety","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schoenberg","sequence":"additional","affiliation":[{"name":"Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Stephen","family":"Jones","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Flexible Blue Light Study Group Collaborators S0022534717780044-5a04cf2a5ccd82b2072e727b96068538 Soroush Bazargani, S0022534717780044-c83d7171d80cbfcb2359acb3b7747dc0 Hoorman Djaladat, S0022534717780044-7e4bc569ea8a7cc34a19053d56c3c4c1 Anne Schuckman, S0022534717780044-bbf66881fd421eb49f472f01bd958cd5 Michael Cookson, S0022534717780044-ada138fbf5d65cbf93cafed628b8f0b2 Brian Cross, S0022534717780044-082618387b6dfe6c2870ddba70bdd60b Kelley Stratton, S0022534717780044-d671eda1234074c9d567d3679993faa6 Costas D","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.11.096_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.eururo.2003.12.016","article-title":"A second-look TUR in T1 transitional cell carcinoma: why?","volume":"45","author":"Jakse","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1464-410X.2004.05715.x","article-title":"5-Aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta\/T1 bladder cancer","volume":"96","author":"Babjuk","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.11.096_bib3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/01.ju.0000181814.73466.14","article-title":"Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","volume":"174","author":"Daniltchenko","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-5347(17)37779-0","article-title":"Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder","volume":"146","author":"Klaen","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib5","first-page":"48","article-title":"[ALA fluorescent diagnosis of bladder cancer]","volume":"5","author":"Al'-Shukri SKh","year":"2000","journal-title":"Urologiia"},{"key":"10.1016\/j.juro.2017.11.096_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-2008-1058226","article-title":"The value of secondary transurethral resection for superficial bladder tumors","volume":"25","author":"K\u00f6hrmann","year":"1994","journal-title":"Akt Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.juro.2017.11.096_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1562\/0031-8655(2002)076<0518:MCOTCS>2.0.CO;2","article-title":"Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells","volume":"76","author":"Krieg","year":"2002","journal-title":"J\u00a0Photochem Photobiol B"},{"key":"10.1016\/j.juro.2017.11.096_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/1011-1344(90)85083-9","article-title":"Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience","volume":"6","author":"Kennedy","year":"1990","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.juro.2017.11.096_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.juro.2007.03.034","article-title":"A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer","volume":"178","author":"Grossman","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib11","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.juro.2010.06.148","article-title":"Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with non-muscle invasive bladder cancer","volume":"184","author":"Stenzl","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib12","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1111\/j.1464-410X.2011.10090.x","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: a randomized two-centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.11.096_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/end.2008.0574","article-title":"Hexaminolevulinate fluorescence cystoscopy and transurethral resection of the bladder in noninvasive bladder tumors","volume":"23","author":"Geavlete","year":"2009","journal-title":"J Endourol"},{"key":"10.1016\/j.juro.2017.11.096_bib14","first-page":"123","article-title":"Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid","volume":"52","author":"Dr\u0103goescu","year":"2011","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.juro.2017.11.096_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2007.03.028","article-title":"A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study","volume":"178","author":"Fradet","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term reduction in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.eururo.2013.07.007","article-title":"Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature","volume":"64","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib18","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.eururo.2014.06.037","article-title":"Clinical and cost effectiveness of hexaminolevulinate-guided blue light cystoscopy: evidence review and updated expert recommendations","volume":"66","author":"Witjes","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib20","first-page":"6682","article-title":"The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation","volume":"20","author":"Garfield","year":"2013","journal-title":"Can J Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib21","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.juro.2017.11.096_bib22","series-title":"AJCC Cancer Staging Handbook, 7th ed","author":"Edge","year":"2010"},{"key":"10.1016\/j.juro.2017.11.096_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.eururo.2004.10.025","article-title":"Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?","volume":"47","author":"Loidl","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib24","author":"Chang"},{"key":"10.1016\/j.juro.2017.11.096_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrurol.2014.245","article-title":"Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA","volume":"11","author":"Daneshmand","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.juro.2017.11.096_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2014.03.006","article-title":"Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data","volume":"84","author":"Witjes","year":"2014","journal-title":"Urology"}],"updated-by":[{"DOI":"10.1097\/ju.0000000000000240","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000}}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717780044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717780044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.11.096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:05:08Z","timestamp":1651194308000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.11.096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1016\/j.juro.2017.11.096"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.11.096","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.11.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}